✦ LIBER ✦

Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival

✍ Scribed by McClune, Brian L.; Ahn, Kwang Woo; Wang, Hai-Lin; Antin, Joseph H.; Artz, Andrew S.; Cahn, Jean-Yves; Deol, Abhinav; Freytes, César O.; Hamadani, Mehdi; Holmberg, Leona A.; Jagasia, Madan H.; Jakubowski, Ann A.; Kharfan-Dabaja, Mohamed A.; Lazarus, Hillard M.; Miller, Alan M.; Olsson, Richard; Pedersen, Tanya L.; Pidala, Joseph; Pulsipher, Michael A.; Rowe, Jacob M.; Saber, Wael; van Besien, Koen W.; Waller, Edmund K.; Aljurf, Mahmoud D.; Akpek, Görgun; Bacher, Ulrike; Chao, Nelson J.; Chen, Yi-Bin; Cooper, Brenda W.; Dehn, Jason; de Lima, Marcos J.; Hsu, Jack W.; Lewis, Ian D.; Marks, David I.; McGuirk, Joseph; Cairo, Mitchell S.; Schouten, Harry C.; Szer, Jeffrey; Ramanathan, Muthalagu; Savani, Bipin N.; Seftel, Matthew; Socie, Gérard; Vij, Ravi; Warlick, Erica D.; Weisdorf, Daniel J.

Book ID: 122287397
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 533 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2014.03.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation of early lymphocyte recovery

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma

✍ Gordan, L N; Sugrue, M W; Lynch, J W; Williams, K D; Khan, S A; Moreb, J S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Different age limits for elderly patient

Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age : Analysis of a population-based non-Hodgkin lymphoma registry

✍ Eduard Maartense; Hanneke C. Kluin-Nelemans; Saskia le Cessie; Philip M. Kluin; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 3 views

Complete response to induction therapy i

Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

✍ Cohen, Jonathon B.; Geyer, Susan M.; Lozanski, Gerard; Zhao, Weiqiang; Heerema, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

A VM 26-based regimen for patients with

A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group

✍ Leo I. Gordon; Janet Andersen; Stephanie Gregory; Joseph Mazza; Paul Chervenick; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Background. The epidophyllotoxin VM 26 has been shown to have single-agent activity in patients with diffuse aggressive lymphoma. In an attempt to determine its activity in combination with other agents known to be effective in lymphoma, a Phase I1 trial of a novel chemotherapy regimen was conducted

Progression-free survival at 2 years is

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

✍ Akamatsu, Hiroaki; Mori, Keita; Naito, Tateaki; Imai, Hisao; Ono, Akira; Shukuya 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 214 KB

The remission status before and the PCR

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma

✍ Moos, M; Schulz, R; Martin, S; Benner, A; Haas, R 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB